CI

Cancer Immunology Immunotherapy

Cancer Immunology, Immunotherapy provides timely open access publication of original discovery and developments in basic and translational research in the field of cancer immunology and immunotherapy. It is an online-only journal and the print ISSN 0340-7004 is ceased.

Looking to publish in Cancer Immunology Immunotherapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Immunology, Oncology
Impact Factor 5.1
Quartile Q1
Open Access Type Open
ISSN 0340-7004
eISSN 1432-0851
Invitation Only No
Cost Range APC: £2990.00 GBP / $4790.00 USD / €3590.00 EUR

Submission Instructions

Cancer Immunology Immunotherapy accepts the following article types. Click on an article type to view submission instructions.

Original Research Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required and must be 150 to 250 words. Abstract must be 150 to 250 words.
Manuscript Manuscript text must not exceed 4000 words. Manuscript must include Introduction, Materials and Methods, Results, and a Discussion that follows the Results section. Manuscript must include 4 to 6 keywords, a section headed 'Statements and Declarations' after the references with funding and competing interests statements, documentation of any LLM use in the Methods or suitable alternative section, and a disclosure statement.
References Reference list must not exceed 45 references. Citations must use numbered references in square brackets. Reference list entries must be numbered consecutively and include only works cited in the text that have been published or accepted for publication, with DOI links included when available.
Figures & Tables Submission is limited to 8 figures and 3 tables. Figures should be submitted within the body of the text unless file size causes upload problems, in which case large figures should be submitted separately. Figures and tables must be numbered with Arabic numerals and cited in the text in consecutive numerical order, and each must have a descriptive caption.
Reformat to Cancer Immunology Immunotherapy using Livewrite Premium

Review

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must be 150 to 250 words.
Manuscript Manuscript must not exceed 4000 words. Manuscript must include 4 to 6 keywords, a statement identifying who had the idea for the article, who performed the literature search and data analysis, and who drafted and/or critically revised the work, a disclosure statement, and a section headed 'Statements and Declarations' after the references including Funding and Competing Interests statements.
References References must not exceed 40. Citations must use numbered references in square brackets. Reference list entries must be numbered consecutively and include only works cited in the text that have been published or accepted for publication, with full DOI links included when available.
Figures & Tables Figures and tables are limited to 2 explanatory items in total. Figures should be submitted within the body of the text unless file size causes upload problems, in which case large figures should be submitted separately. Figures and tables must be numbered with Arabic numerals, cited in consecutive numerical order, and accompanied by concise descriptive captions, with figure captions included in the manuscript text file rather than in the figure files.
Reformat to Cancer Immunology Immunotherapy using Livewrite Premium

Meta-Analysis Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must be 150 to 250 words.
Manuscript Manuscript must not exceed 3000 words. Manuscript must describe a rigorous methodological/statistical approach in detail in the Methods section. Manuscript must include 4 to 6 keywords and a section headed 'Statements and Declarations' after the References section that includes Funding and Competing Interests statements, and any use of an LLM must be documented in the Methods section or a suitable alternative section if no Methods section is available.
References References must not exceed 100. Citations must be numbered in square brackets in the text, and the reference list must include only cited published or accepted works numbered consecutively with full DOI links when available.
Figures & Tables Figures should be embedded within the manuscript text unless file size causes upload problems, in which case large figures should be submitted separately. Tables and figures must be numbered with Arabic numerals, cited in consecutive numerical order, and accompanied by captions, with figure captions included in the manuscript text file rather than in the figure file.
Reformat to Cancer Immunology Immunotherapy using Livewrite Premium

Brief Research Reports

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must be 150 to 250 words.
Manuscript Brief Research Reports must not exceed 2000 words. Manuscript must include an Introduction, Materials and Methods, Results, and a Discussion that follows the Results section. Manuscript must include 4 to 6 keywords, a section headed 'Statements and Declarations' after the References section including Funding and Competing Interests statements, and documentation of any LLM use in the Methods section or a suitable alternative part if no Methods section is available.
References Brief Research Reports must not exceed 20 references. Citations must be numbered in square brackets. Reference list entries must be numbered consecutively and include only works cited in the text that have been published or accepted for publication, with full DOI links included when available.
Figures & Tables Brief Research Reports are limited to 4 figures and 2 tables. Figures should be submitted within the body of the text unless file size causes upload problems, in which case large figures should be submitted separately. Each figure and table must be numbered with Arabic numerals, cited in consecutive numerical order in the text, and accompanied by a caption.
Reformat to Cancer Immunology Immunotherapy using Livewrite Premium

Letter To The Editor

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not be included.
Manuscript Manuscript must not exceed 750 words. Manuscript must include a section headed 'Statements and Declarations' after the References section, must document any LLM use in the Methods section or another suitable part if no Methods section is available, and must not include keywords.
References Reference list may include up to 5 references. Citations must be identified by numbers in square brackets. Reference list entries must be numbered consecutively and include only works cited in the text that have been published or accepted for publication.
Figures & Tables Submission may include 1 figure. Figures should be submitted within the body of the text unless file size causes upload problems, in which case large figures should be submitted separately. Each figure must be numbered with Arabic numerals, cited in consecutive numerical order, and accompanied by a concise caption included in the manuscript text file rather than in the figure file.
Reformat to Cancer Immunology Immunotherapy using Livewrite Premium

Clinical Trial Reports

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must be 150 to 250 words. For Clinical Trial Reports, the last line of the abstract must state the trial registration number and date of registration for prospectively registered trials, or the trial registration number, date of registration, and the words 'retrospectively registered' for trials not registered prospectively.
Manuscript Manuscript text must not exceed 4000 words. The manuscript must include Introduction, Materials and Methods, Results, and a Discussion that follows the Results section. The manuscript must include 4 to 6 keywords, a section headed 'Statements and Declarations' after the References section with Funding and Competing Interests statements, documentation of any LLM use in the Methods section or suitable alternative part, and relevant immunological data.
References Reference list must not exceed 45 references. Citations must use numbered references in square brackets. References must be listed consecutively in numerical order and include only works cited in the text that have been published or accepted for publication.
Figures & Tables Clinical Trial Reports are limited to 8 figures and 3 tables. Figures should be embedded within the manuscript text unless file size causes upload problems, in which case large figures should be submitted separately. Figures and tables must be numbered with Arabic numerals, cited in consecutive numerical order in the text, and accompanied by descriptive captions.
Reformat to Cancer Immunology Immunotherapy using Livewrite Premium

Recent Publications

HDAC6 inhibitor ACY-1215 enhances STAT1 acetylation to block PD-L1 for colorectal cancer immunotherapy

Yuqing Wen, Shuyu Ye, Zhengshuo Li, Xiaoyue Zhang, Can Liu, Yangge Wu, Run Zheng, Chenxiao Xu, Junrui Tian, Lanjun Shu, Qun Yan, Feiyan Ai, Jian Ma

10.1007/s00262-023-03624-y
View Publication

Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8+ clonal effector and CAR T-cell function while promoting a senescence-associated phenotype

Russell Towers, Lidia Trombello, Maximilian Fusenig, Antje Tunger, Anna-Lena Baumann, Roberto Savoldelli, Rebekka Wehner, Frederick Fasslrinner, Claudia Arndt, Francesco Dazzi, Malte Von Bonin, Anja Feldmann, Michael P. Bachmann, Manja Wobus, Marc Schmitz, Martin Bornhäuser

10.1007/s00262-023-03594-1
View Publication

Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastases

Celine Man Ying Li, Yoko Tomita, Bimala Dhakal, Teresa Tin, Runhao Li, Josephine A. Wright, Laura Vrbanac, Susan L. Woods, Paul Drew, Timothy Price, Eric Smith, Guy J. Maddern, Kevin Fenix

10.1007/s00262-023-03591-4
View Publication

Rescue of NLRC5 expression restores antigen processing machinery in head and neck cancer cells lacking functional STAT1 and p53

Brendan L. C. Kinney, Sreenivasulu Gunti, Vikash Kansal, Connor J. Parrish, Nabil F. Saba, Yong Teng, Mary Katherine Henry, Fang-Yi Su, Gabriel A. Kwong, Nicole C. Schmitt

10.1007/s00262-023-03589-y
View Publication

A novel model for predicting prognosis and response to immunotherapy in nasopharyngeal carcinoma patients

Ya-Xian Wu, Bo-Yu Tian, Xin-Yuan Ou, Meng Wu, Qi Huang, Run-Kun Han, Xia He, Shu-Lin Chen

10.1007/s00262-023-03626-w
View Publication

Frequently asked questions

How long does it take to publish?

Submission to first decision (median): 2 days.

Reformat to Cancer Immunology Immunotherapy using Livewrite Premium

Is a cover letter required?

A submission letter is referenced for suggesting reviewers, including institutional email addresses or other identity verification for suggested reviewers.

Reformat to Cancer Immunology Immunotherapy using Livewrite Premium

What are the publication costs?

Article processing charge: £2990.00 GBP / $4790.00 USD / €3590.00 EUR, plus VAT or local taxes where applicable.

Reformat to Cancer Immunology Immunotherapy using Livewrite Premium

Research Topics

Immunotherapy and Immune Responses Immune Cell Function and Interaction Cancer Immunotherapy and Biomarkers CAR-T cell therapy research T-cell and B-cell Immunology Monoclonal and Polyclonal Antibodies Research Immune cells in cancer Glycosylation and Glycoproteins Research Immune Response and Inflammation Virus-based gene therapy research vaccines and immunoinformatics approaches Cancer Research and Treatments RNA Interference and Gene Delivery Lymphoma Diagnosis and Treatment Cancer Cells and Metastasis Toxin Mechanisms and Immunotoxins Bladder and Urothelial Cancer Treatments Lung Cancer Treatments and Mutations Lung Cancer Research Studies Chemokine receptors and signaling Pancreatic and Hepatic Oncology Research Hematopoietic Stem Cell Transplantation Ferroptosis and cancer prognosis Peptidase Inhibition and Analysis Chronic Lymphocytic Leukemia Research

Related Journals

EI
Emerging Infectious Diseases CENTERS DISEASE CONTROL & PREVENTION
OI
Osteoporosis International Springer Science+Business Media
IJ
International Journal Of Oncology Spandidos Publishing
AO
Annals Of Allergy Asthma & Immunology Elsevier BV
BC
Breast Cancer Research BioMed Central
SI
Seminars In Cancer Biology Elsevier BV